市场调查报告书
商品编码
1274202
移动心臟遥测设备全球市场研究报告-2023-2030 年行业分析、规模、份额、增长、趋势和预测Global Mobile Cardiac Telemetry Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
全球对移动心臟遥测设备的需求将从 2022 年的 9.5007 亿美元增长到 2030 年的近 24.5669 亿美元,预计在 2023-2030 年研究期间将达到 12.6% 的复合年增长率。
移动心臟遥测 (MCT) 设备是一种小型可穿戴设备,可以持续监测患者的心律和其他心臟参数。 它用于诊断和监测引起心悸、头晕和呼吸急促等症状的房颤等心律失常。 该设备通常佩戴长达 30 天,在此期间它会记录患者的心跳和其他心臟数据。 他们也可能有一个内置的事件监视器,允许您记录患者在监视期间经历的症状。 MCT 收集的数据被无线传输到监测中心,在那里可以由训练有素的专业人员进行分析,以快速识别患者心律的异常情况。
心律失常、心房颤动和心力衰竭等心血管疾病的发病率不断上升,推动了对移动心臟遥测设备的需求。 据美国心臟协会称,心血管疾病每年导致超过 1700 万人死亡。 这证实了MCT设备存在广阔的市场。 具有实时监测、无线连接和自动分析等功能的新型先进移动心臟遥测设备的开发正在推动市场的增长。 这些设备比传统的心臟监测方法更方便、更准确,因此受到患者和医疗保健提供者的欢迎。 降低医疗保健成本、改善患者治疗效果和提供更方便的护理的需求正在推动远程患者监护 (RPM) 的快速采用。 移动心臟遥测设备已成为 RPM 的关键组成部分,因为它们允许医疗保健专业人员远程监控患者的心臟健康状况。 随着医疗保健提供者寻找为个体患者量身定制护理的方法,对个性化医疗的需求正在增长。 移动心臟遥测设备提供有关患者心臟健康的详细信息,可用于製定个性化治疗计划。
这份研究报告描述了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外,这些工具还能够全面评估全球移动心臟遥测设备市场的各个细分市场。 移动心臟遥测设备行业的发展和趋势为这项研究提供了一种整体方法。
本部分提供有关国家和地区细分的详细数据,以帮助战略制定者确定各自产品或服务的目标受众,并将他们与未来的商机联繫起来。.
本部分涵盖区域展望,重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲移动心臟遥测设备市场当前和未来的需求。 此外,我们还关注所有主要地区各个应用领域的需求、估计和预测。
这份研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 移动心臟遥测设备市场的主要参与者是 BioTelemetry Inc.、ScottCare、Biotricity Inc.、Welch Allyn、Applied Cardiac Systems Inc.、Medicomp Inc.、Preventice Solutions、Telerhythmics LLC、Zoll Medical Corporation、iRhythm Technologies Inc.。本节涵盖它包括竞争格局的完整图景,包括各种战略发展,例如,主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。
注意:公司简介中的财务细节和近期发展基于可用信息,可能不包括私营公司。
The global demand for Mobile Cardiac Telemetry Device Market is presumed to reach the market size of nearly USD 2456.69 MN by 2030 from USD 950.07 MN in 2022 with a CAGR of 12.6% under the study period 2023 - 2030.
A Mobile Cardiac Telemetry or MCT device is a small, wearable device that continuously monitors a patient's heart rhythm and other cardiac parameters. It is used to diagnose and monitor cardiac arrhythmias, such as atrial fibrillation, which may cause symptoms such as palpitations, dizziness, and shortness of breath. The device is typically worn for a period of up to 30 days, during which time it records the patient's heart rhythm and other cardiac data. The device may also have a built-in event monitor that allows the patient to record any symptoms they experience during the monitoring period. The data collected by the MCT device is transmitted wirelessly to a monitoring center, where it is analyzed by trained professionals who can quickly identify any abnormalities in the patient's heart rhythm.
The increasing incidence of cardiovascular diseases such as arrhythmias, atrial fibrillation, and heart failure is driving the demand for Mobile Cardiac Telemetry Devices. The American Heart Association states that cardiovascular disease accounts for over 17 million deaths annually. This supports the availability of a wide MCT device market. The development of new and advanced Mobile Cardiac Telemetry Devices with features such as real-time monitoring, wireless connectivity, and automated analysis is driving the growth of the market. These devices are more convenient and accurate than traditional cardiac monitoring methods, making them popular among patients and healthcare providers. The adoption of remote patient monitoring (RPM) is increasing rapidly, driven by the need to reduce healthcare costs, improve patient outcomes, and provide more convenient care. Mobile Cardiac Telemetry Devices are an important part of RPM, as they allow healthcare providers to monitor patients' cardiac health remotely. The demand for personalized medicine is increasing as healthcare providers look for ways to tailor treatments to individual patients. Mobile Cardiac Telemetry Devices provide detailed information about patients' cardiac health, which can be used to develop personalized treatment plans.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mobile cardiac telemetry device. The growth and trends of mobile cardiac telemetry device industry provide a holistic approach to this study.
This section of the mobile cardiac telemetry device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Mobile Cardiac Telemetry Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mobile cardiac telemetry device market include BioTelemetry Inc., ScottCare, Biotricity Inc., Welch Allyn, Applied Cardiac Systems Inc., Medicomp Inc., Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation, iRhythm Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies